Intensive care unit versus high-dependency care unit admission on mortality in patients with septic shock: a retrospective cohort study using Japanese claims data.
Journal Information
Full Title: J Intensive Care
Abbreviation: J Intensive Care
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Critical Care Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"availability of data and materials no data are available. declarations ethics approval and consent to participate the study protocol was approved by the ethics committee of kyoto university graduate school and faculty of medicine (r2653"
"Declarations Ethics approval and consent to participateThe study protocol was approved by the Ethics Committee of Kyoto University Graduate School and Faculty of Medicine (R2653). Consent for publicationNot applicable. Competing interestsKoji Kawakami has received research funds from Eisai Co., Ltd.; Kyowa Kirin Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Pfizer Inc.; Stella Pharma Corporation; CMIC Co., Ltd.; Suntory Beverage & Food Ltd.; Mitsubishi Corporation, and Real World Data Co., Ltd.; consulting fees from LEBER Inc.; JMDC Inc.; Shin Nippon Biomedical Laboratories Ltd.; Kaken Pharmaceutical Co., Ltd.; and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems; Inc.; honorarium from Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, and Pharma Business Academy; and holds stock in Real World Data Co., Ltd. Competing interests Koji Kawakami has received research funds from Eisai Co., Ltd.; Kyowa Kirin Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd.; Pfizer Inc.; Stella Pharma Corporation; CMIC Co., Ltd.; Suntory Beverage & Food Ltd.; Mitsubishi Corporation, and Real World Data Co., Ltd.; consulting fees from LEBER Inc.; JMDC Inc.; Shin Nippon Biomedical Laboratories Ltd.; Kaken Pharmaceutical Co., Ltd.; and Advanced Medical Care Inc.; executive compensation from Cancer Intelligence Care Systems; Inc.; honorarium from Mitsubishi Chemical Holdings Corporation, Mitsubishi Corporation, and Pharma Business Academy; and holds stock in Real World Data Co., Ltd."
"Funding Not applicable."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025